| Application no. and date | 21202979.7 (espacenet) (Federated) (European Patent Register), 20180226 | | Patent/reg. no. and date | DK/EP 4014976, 20240904 | | Publication date | 20220622 | | Priority no. and date | WO PCT/EP2017/054489, 20170227, WO PCT/EP2017/061487, 20170512 | | EP pub. no. and date |
EP 4014976 20220622 | | Effective date | | | Applicant/owner | Idorsia Pharmaceuticals Ltd, Hegenheimermattweg 91
4123 Allschwil, CH | | Applicant ref. no. | P85212DK01 | | Inventor | BOLLI, Martin,
4123 Allschwil, CH,
BELLET, Marc,
4123 Allschwil, CH,
CLOZEL, Martine,
4123 Allschwil, CH,
IGLARZ, Marc,
4123 Allschwil, CH | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/401 (2006.01) , A61K 31/4035 (2006.01) , A61K 31/41 (2006.01) , A61K 31/506 (2006.01) , A61K 38/05 (2006.01) , A61K 45/06 (2006.01) , A61P 9/12 (2006.01) | | Title | APROCITENTAN TIL ANVENDELSE I BEHANDLINGEN AF HYPERTENSION OG RELATEREDE SYGDOMME I KOMBINATION MED VALSARTAN | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
